Adoption of hypofractionated radiotherapy for early-stage invasive breast cancer after publication of randomized trials.
Ronald C. Chen
No relevant relationships to disclose
Aaron David Falchook
No relevant relationships to disclose
Laura H. Hendrix
No relevant relationships to disclose
Reshma Jagsi
Consultant or Advisory Role - Eviti
Research Funding - AbbVie